Chile vs South-East Asia (WHO region): New cases tested for RR-/MDR-TB
Chile
100.0%
in 2024
South-East Asia (WHO region)
91.0%
in 2024
Chile rank
1st
South-East Asia (WHO region) rank
1st
New cases tested for RR-/MDR-TB over time
- Chile
- South-East Asia (WHO region)
How they compare
Chile currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.
That makes Chile's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 2 times across 20 shared years of data; in 2005 it was Chile ahead.
Chile ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.1% | 0.1% | 3.9% | Chile |
| 2010s | 53.6% | 22.0% | 31.5% | Chile |
| 2020s | 95.2% | 77.8% | 17.4% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Chile or South-East Asia (WHO region)?
- Chile, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Chile and South-East Asia (WHO region)?
- 9.0%, with Chile ahead.
- How many years of comparable data are there for Chile and South-East Asia (WHO region)?
- 20 years are reported by both, from 2005 to 2024.
- How do Chile and South-East Asia (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Chile ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.